TGFβ1, an epidermal controller of skin dendritic cell homeostasis

Journal of Investigative Dermatology

Volumn 133, Issue 1, 2013, Pages 9-11

  Kitoh, Akihiko ^a   Nomura, Takashi ^a   Kabashima, Kenji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD103 ANTIGEN; CD11B ANTIGEN; CD86 ANTIGEN; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 6; LANGERIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ARTHRITIS; CD4+ T LYMPHOCYTE; CELL SUBPOPULATION; DENDRITIC CELL; DERMATITIS; HOMEOSTASIS; HUMAN; IMMUNOPATHOGENESIS; KERATINOCYTE; LANGERHANS CELL; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; PSORIASIS; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL;

EID: 84872173903     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2012.411     Document Type: Note

References (16)

1. Bettelli E, Carrier Y, Gao W et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-88
2. Blobe GC, Schiemann WP, Lodish HF (2000) Role of transforming growth factor beta in human disease. N Engl J Med 342:1350-88
3. Egawa G, Honda T, Tanizaki H et al. (2011) In vivo imaging of T-cell motility in the elicitation phase of contact hypersensitivity using two-photon microscopy. J Invest Dermatol 131:977-99
4. Egawa G, Kabashima K (2011) Skin as a peripheral lymphoid organ: Revisiting the concept of skin-associated lymphoid tissues. J Invest Dermatol 131:2178-855
5. Fitch EL, Rizzo HL, Kurtz SE et al. (2009) Inflammatory skin disease in K5.hTGF-beta1 transgenic mice is not dependent on the IL-23/Th17 inflammatory pathway. J Invest Dermatol 129:2443-500
6. Han G, Williams CA, Salter K et al. (2010) A role for TGFbeta signaling in the pathogenesis of psoriasis. J Invest Dermatol 130:371-77
7. Honda T, Egawa G, Grabbe S et al. (2012) Update of immune events in the murine contact hypersensitivity model: Toward the understanding of allergic contact dermatitis. J Invest Dermatol; e-pub ahead of print 30 August 20122
8. Kallimanis PG, Xenos K, Markantonis SL et al. (2009) Serum levels of transforming growth factor-beta1 in patients with mild psoriasis vulgaris and effect of treatment with biological drugs. Clin Exp Dermatol 34:582-66
9. Li AG, Wang D, Feng XH et al. (2004) Latent TGFbeta1 overexpression in keratinocytes results in a severe psoriasis-like skin disorder. Embo J 23:1770-811
10. Li MO, Wan YY, Sanjabi S et al. (2006) Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24:99-1466
11. Liu X, Alexander V, Vijayachandra K et al. (2001) Conditional epidermal expression of TGFbeta 1 blocks neonatal lethality but causes a reversible hyperplasia and alopecia. Proc Natl Acad Sci USA 98:9139-444
12. Michaelis K, Wallbrecht K, Kerstan A et al. (2010) Modulating T cell functions does not alleviate chronic inflammatory skin lesions in K5.TGF beta 1 transgenic mice. Exp Dermatol 19:406-155
13. Mohammed J, Gunderson AJ, Khong HH et al. (2012) TGFb1 overexpression by keratinocytes alters skin dendritic cell homeostasis and enhances contact hypersensitivity. J Invest Dermatol 133:135-433
14. Rubtsov YP, Rudensky AY (2007) TGFbeta signalling in control of T-cell-mediated selfreactivity. Nat Rev Immunol 7:443-533
15. Veldhoen M, Stockinger B (2006) TGFbeta1, a ''Jack of all trades'': The link with proinflammatory IL-17-producing T cells. Trends Immunol 27:358-611
16. Wahl SM (1994) Transforming growth factor beta: The good, the bad, and the ugly. J Exp Med 180:1587-900